These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7658)

  • 1. Dopamine in substantia nigra and cortex after gamma-butyrolactone treatment.
    Pericić D; Walters JR
    J Pharm Pharmacol; 1976 Jun; 28(6):527-30. PubMed ID: 7658
    [No Abstract]   [Full Text] [Related]  

  • 2. Transmitter metabolism in substantia nigra after inhibition of dopaminergic neurones by butyrolactone.
    Hefti F; Lienhart R; Lichtensteiger W
    Nature; 1976 Sep; 263(5575):341-3. PubMed ID: 958491
    [No Abstract]   [Full Text] [Related]  

  • 3. Subcellular distribution of dopamine in substantia nigra of the rat brain: effects of gamma-butyrolactone and destruction of noradrenergic afferents suggest formation of particles from dendrites.
    Hefti F; Lichtensteiger W
    J Neurochem; 1978 Jun; 30(6):1217-30. PubMed ID: 209130
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential effect of acute and chronic ethanol on dopamine metabolism in frontal cortex, caudate nucleus and substantia nigra.
    Fadda F; Argiolas A; Melis MR; Serra G; Gessa GL
    Life Sci; 1980 Sep; 27(11):979-86. PubMed ID: 7432099
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of ethanol on the metabolism of regional brain dopamine.
    Fadda F; Argiolas A; Melis MR; Serra G; Congia S
    Boll Soc Ital Biol Sper; 1980 Dec; 56(24):2559-63. PubMed ID: 7470303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of acute and chronic ethanol on dopamine synthesis in the caudate nucleus, substantia nigra and frontal cortex.
    Fadda F; Argiolas A; Melis MR; Serra G
    Boll Soc Ital Biol Sper; 1980 Dec; 56(24):2553-8. PubMed ID: 7470302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of neuroleptics on the nigroneostriatal and mesocortical dopaminergic systems.
    Glowinski J
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():233-46. PubMed ID: 769114
    [No Abstract]   [Full Text] [Related]  

  • 8. Suppression of nigrostriatal and mesolimbic dopamine release in vivo following noradrenaline depletion by DSP-4: a microdialysis study.
    Lategan AJ; Marien MR; Colpaert FC
    Life Sci; 1992; 50(14):995-9. PubMed ID: 1372673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gamma-butyrolactone sleep: A 24-hour rhythm paralleling normal sleep in the rat and CNS amine changes.
    Speciale SG; Friedman AH
    Pharmacol Biochem Behav; 1975; 3(5):761-4. PubMed ID: 1208618
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo release of acetylcholinesterase in cat substantia nigra and caudate nucleus.
    Greenfield S; Cheramy A; Leviel V; Glowinski J
    Nature; 1980 Mar; 284(5754):355-7. PubMed ID: 7360271
    [No Abstract]   [Full Text] [Related]  

  • 11. Presence of dopaminergic terminals and absence of dopaminergic cell bodies in the cerebral cortex of the cat.
    Thierry AM; Hirsch JC; Tassin JP; Blanc G; Glowinski J
    Brain Res; 1974 Oct; 79(1):77-88. PubMed ID: 4425954
    [No Abstract]   [Full Text] [Related]  

  • 12. d-Amphetamine and gamma-butyrolactone alteration of dopamine synthesis in the terminals of nigrostriatal and mesolimbic neurons. Possible role of various autoreceptor sensitivities.
    Demarest KT; Lawson-Wendling KL; Moore KE
    Biochem Pharmacol; 1983 Feb; 32(4):691-7. PubMed ID: 6403019
    [No Abstract]   [Full Text] [Related]  

  • 13. Nigral and striatal dopamine release under sensory stimuli.
    Nieoullon A; Cheramy A; Glowinski J
    Nature; 1977 Sep; 269(5626):340-2. PubMed ID: 904687
    [No Abstract]   [Full Text] [Related]  

  • 14. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electron microscopic localization of labeled norepinephrine transported in nigro-striatal neurons.
    McGeer EG; Hattori T; McGeer PL
    Brain Res; 1975 Mar; 86(3):478-82. PubMed ID: 46770
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence for a direct action of amphetamine on dopamine metabolism in the rat substantia nigra in vivo.
    Argiolas A; Fadda F; Stefanini E; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1978; 301(3):171-4. PubMed ID: 634376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic haloperidol causes persistent increase in 3,4-dihydroxyphenylacetic acid (DOPAC) concentration in the substantia nigra but not in the ventral tegmental area.
    Argiolas A; Fadda F; Melis MR; Serra G; Gessa GL
    Brain Res; 1979 Oct; 175(1):178-82. PubMed ID: 487148
    [No Abstract]   [Full Text] [Related]  

  • 18. Release of dopamine in the ventral tegmental area of rat.
    Fadda F; Melis MR; Argiolas A; Perra G
    Boll Soc Ital Biol Sper; 1979 Jul; 55(12):1178-83. PubMed ID: 553533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine, a modulator of carbohydrate metabolism in the caudate nucleus.
    Anchors JM; Garcia-Rill E
    Brain Res; 1977 Sep; 133(1):183-9. PubMed ID: 902086
    [No Abstract]   [Full Text] [Related]  

  • 20. Disposition of newly synthesized amines in cell bodies and terminals of central catechol aminergic neurons. I. Effect of amphetamine and thiorproperazine on the metabolism of CA in the caudate nucleus, the substantia nigra and the ventromedial nucleus of the hypothalamus.
    Javoy F; Hamon M; Glowinski J
    Eur J Pharmacol; 1970 May; 10(2):178-88. PubMed ID: 4393431
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.